Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › UT › Salt Lake City › NPI 1073549614
Agency

Planned Parenthood Association of Utah

Planned Parenthood Association of Utah was paid $1.38M by Medicaid between Jan 2018 and Dec 2024, across 28 billing codes. Its largest line is 87491, Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe — 23% of everything it billed.

33Billing provider infoPLANNED PARENTHOOD ASSOCIATION OF UTAH
SALT LAKE CITY, UT 84102
33aNPI1073549614assigned 06/24/2006
28Total paid$1.38M
24GClaims40,080
24DCodes billed28
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service

Paid by month

$0$25K$50K$75K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018983$12K
20191,652$32K
20204,305$149K
20219,984$407K
202212,203$495K
20236,924$202K
2024incomplete4,029$81K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 23% 7,359 6,959 $319K
81025 14% 5,641 5,439 $199K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 13% 2,258 2,189 $176K
J7307 Etonogestrel (contraceptive) implant system, including implant and supplies 13% 327 317 $174K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 10% 2,869 2,801 $138K
J1050 Injection, medroxyprogesterone acetate, 1 mg 8.9% 3,317 3,261 $123K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward 5.2% 1,486 1,462 $71K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 2.8% 7,359 6,959 $39K
99203 Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity 1.6% 339 331 $22K
J7297 Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg 1.6% 66 65 $22K
58300 1.3% 352 349 $17K
11981 1.2% 178 175 $17K
16 more codes
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 677 $12K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 2,228 $10K
11982 <1% 107 $7K
86703 <1% 858 $6K
58301 <1% 111 $6K
99201 <1% 110 $5K
83986 <1% 1,572 $5K
99214 Doctor's office visit, returning patient (more involved) <1% 13 $4K
J3490 Unclassified drugs <1% 137 $3K
87210 <1% 1,857 $2K
99000 <1% 461 $313.29
81002 <1% 145 $263.26
87390 <1% 55 $170.51
36415 Collection of venous blood by venipuncture <1% 132 $110.08
86592 <1% 52 $83.34
Q0144 Azithromycin dihydrate, oral, capsules/powder, 1 gram <1% 14 $69.47

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGALLOWAY, KARRIE (CEO/PRESIDENT)